Rapid Infusion Daratumumab Is Safe in Patients with AL Amyloidosis

被引：1
|
作者：
Rosko, Nathaniel [1 ]
Mo, Hanjie [1 ]
Rudoni, Joslyn [1 ]
Siebenaller, Caitlin [1 ]
Lee, Sarah S. [2 ]
Chakraborty, Rajshekar [2 ]
Faiman, Beth M. [2 ]
Khouri, Jack [2 ]
Garcia, Alex V. Mejia [2 ]
Samaras, Christy J. [2 ]
Anwer, Faiz [2 ]
Valent, Jason [2 ]
机构：
[1] Cleveland Clin, Dept Pharm, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-124775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1838
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Abeykoon, Jithma P.
    Zanwar, Saurabh
    Dispenzieri, Angela
    Gertz, Morie A.
    Leung, Nelson
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Muchtar, Eli
    Dingli, David
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, Vincent
    Kumar, Shaji
    Kapoor, Prashant
    LEUKEMIA, 2019, 33 (02) : 531 - 536
  • [22] Daratumumab (DARA) is Highly Effective Therapeutic Intervention in Patients with AL Amyloidosis (AA)
    Alhuraiji, Ahmad
    Alshemmari, Salem
    Ram, Mohan
    Kunhikrishnan, Anitha
    Ghonema, Rasha
    Hasaneen, Mahmoud
    Refaat, Reneah
    Pandita, Ramesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S251 - S251
  • [23] Front-line daratumumab in newly diagnosed AL amyloidosis patients.
    Kennedy, Vanessa Elaine
    Shah, Nina
    Wolf, Jeffrey Lee
    Martin, Thomas G.
    Wong, Sandy Wai Kuan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
    Jithma P. Abeykoon
    Saurabh Zanwar
    Angela Dispenzieri
    Morie A. Gertz
    Nelson Leung
    Taxiarchis Kourelis
    Wilson Gonsalves
    Eli Muchtar
    David Dingli
    Martha Q. Lacy
    Suzanne R. Hayman
    Francis Buadi
    Rahma Warsame
    Robert A. Kyle
    Vincent Rajkumar
    Shaji Kumar
    Prashant Kapoor
    Leukemia, 2019, 33 : 531 - 536
  • [25] Safety and feasibility analysis of rapid daratumumab infusion in Chinese patients with multiple myeloma
    Yin, Xi-xi
    Hu, Yueyun
    Yang, Yusi
    Zhang, Xinglan
    Liu, Li
    Cao, Xi
    Chen, Jianwen
    Xia, Zhongjun
    Wang, Ye
    CANCER MEDICINE, 2024, 13 (11):
  • [26] Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
    Palladini, Giovanni
    Milani, Paolo
    Malavasi, Fabio
    Merlini, Giampaolo
    CELLS, 2021, 10 (03) : 1 - 11
  • [27] Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis
    Hughes, Michael Sang
    Lentzsch, Suzanne
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 1063 - 1074
  • [28] Ninety-minute daratumumab infusion is safe in multiple myeloma
    Hallie Barr
    Jessica Dempsey
    Allyson Waller
    Ying Huang
    Nita Williams
    Nidhi Sharma
    Don M. Benson
    Ashley E. Rosko
    Yvonne A. Efebera
    Craig C. Hofmeister
    Leukemia, 2018, 32 : 2495 - 2518
  • [29] Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma
    Barr, Hallie
    Dempsey, Jessica
    Waller, Allyson
    Huang, Ying
    Williams, Nita
    Sharma, Nidhi
    Benson, Don M., Jr.
    Rosko, Ashley E.
    Efebera, Yvonne A.
    Hofmeister, Craig C.
    BLOOD, 2017, 130
  • [30] Ninety-minute daratumumab infusion is safe in multiple myeloma
    Barr, Hallie
    Dempsey, Jessica
    Waller, Allyson
    Huang, Ying
    Williams, Nita
    Sharma, Nidhi
    Benson, Don M.
    Rosko, Ashley E.
    Efebera, Yvonne A.
    Hofmeister, Craig C.
    LEUKEMIA, 2018, 32 (11) : 2495 - 2497
12345